Monthly educational series for Ophthalmologist, Optometrist, community optometrists, residents, fellows, medical students, and researchers.
Key Words: Ophthalmology, Retina, Glaucoma, Retinal diseases, Cornea, Oculoplastic, Neuro-ophthalmology, Uveitis
- Ophthalmologists
- Optometrists
- Community Physicians
- Residents/Fellows
- Medical Students
Participants who engage in this educational intervention will be able to:
- Discuss the various pseudo-retinoblastoma presentations and describe clinical tips to differentiate them from retinoblastoma.
- Describe the various presentations of pediatric conjunctival lesions including inflammatory, infectious and neoplastic lesions and to discuss the diseases that would require surgical excision for confirmatory histo-pathology
- Discuss the presentation of various congenital, inflammatory and neoplastic uveal lesions in children and to elaborate the utility of ancillary testing and role of fine needle aspiration biopsy
William Wirostko, MD
Professor
Department of Ophthalmology and Visual Sciences
The Medical College of Wisconsin
- William Wirostko
Name | Company | Role |
|---|---|---|
Aparna Ramasubramanian, MD | Day One Biopharmaceuticals - Advisory Board | Advisory Committee |
Contact
ACCME Accreditation Statement:
The Medical College of Wisconsin is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
AMA Credit Designation Statement:
The Medical College of Wisconsin designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Hours of Participation for Allied Health Care Professionals:
The Medical College of Wisconsin designates this activity for up to 1.00 hours of participation for continuing education for allied health professionals.
- 1.00 AMA PRA Category 1 Credit(s)™AMA PRA Category 1 Credit(s)™
- 1.00 Hours of ParticipationHours of Participation credit.

Facebook
X
LinkedIn
Forward